INOVIQ Exosome Diagnostic Solutions

Market potential | Screening and monitoring tests For personal use only 15 Ovarian cancer - EU5 ■ US ■ AU Statistics¹ Eligible screening population² Eligible monitoring population³ Global Market size 4,5 Ovarian cancer incidence 52,638 Ovarian cancer prevalence 154,831 Breast cancer incidence 543,972 4.0 60.4 119m 54.7 11.5 188.3 $1.9b 367k 167.3 GLOBAL DX MARKET (Millions of people) (Thousands of people) (US$ billions) 4.0 Breast cancer 54.7 119m ■ EU5 - US Breast cancer prevalence 2,279,467 ■ AU (Millions of people) 60.4 2.1 0.2 4.46m (Millions of people) 2.2 $4.2b GLOBAL DX MARKET (US$ billions) 1 Source: https://gco.iarc.fr/today/home covering US, EU5 and AU; 2. Females 50-79yrs covering US, EU5 and AU (Source: https://www.populationpyramid.net ).; 3. Monitoring population based on 4x incidence plus 1x prevalence; 4. https://www.globenewswire.com/news-release/2019/08/07/1898453/0/en/Ovarian-Cancer-Diagnostics-Market-Size-Worth-US-1-8-Bn-by-2026.html 5. https://www.grandviewresearch.com/industry-analysis/breast-cancer-diagnostics-market INOVIQ

View entire presentation